Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Kagramanova A.V
131  Ergebnisse:
Personensuche X
?
1

P338 The dependence of the level of Glycoprotein type 2 on ..:

Knyazev, O ; Kagramanova, A V ; Lishchinskaya, A.
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i731-i731 , 2024
Link: https://doi.org/10.1093/..
 
?
2

CROHN'S DISEASE. TO THE 90th ANNIVERSARY OF THE DESCRIPTION:

Shkurko, T. V. ; Kagramanova, A. V. ; Knyazev, O. V.
Problems of Social Hygiene, Public Health and History of Medicine.  30 (2022)  s1 - p. 1162-1166 , 2022
Link: https://doi.org/10.32687..
 
?
3

P273 The duration of clinical remission in patients with Cr..:

Knyazev, O ; Kagramanova, A V ; Lishchinskaya, A...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S306-S306 , 2021
Link: https://doi.org/10.1093/..
 
?
4

P320 Combined mesenchymal stromal cells and anti-cytokine t..:

Knyazev, O ; Kagramanova, A V ; Lishchinskaya, A...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S346-S347 , 2021
Link: https://doi.org/10.1093/..
 
?
5

P270 Mesenchymal stromal cells contribute to the recovery o..:

Knyazev, O ; Kagramanova, A V ; Lishchinskaya, A...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S304-S304 , 2021
Link: https://doi.org/10.1093/..
 
?
6

Loss of response and frequency of adverse events in patient..:

Knyazev, O. V. ; Zvyaglova, M. Yu. ; Kagramanova, A. V....
Terapevticheskii arkhiv.  93 (2021)  2 - p. 150-157 , 2021
Link: https://doi.org/10.26442..
 
?
7

P617 Mesenchymal stromal cells of bone marrow reduce the ri..:

Knyazev, O ; Kagramanova, A V ; Lishchinskaya, A.
Journal of Crohn's and Colitis.  14 (2020)  Supplement_1 - p. S513-S514 , 2020
Link: https://doi.org/10.1093/..
 
?
8

Systemic manifestations of inflammatory bowel diseases:

Parfenov, A. I. ; Kagramanova, A. V. ; Knyazev, O. V.
Terapevticheskii arkhiv.  92 (2020)  2 - p. 4-11 , 2020
Link: https://doi.org/10.26442..
 
?
9

O.V. Knyazev, A.V. Kagramanova, I.A. Korneeva, K.K. Noskova..:

Knyazev, O V ; Kagramanova, A V ; Korneeva, I A...
Terapevticheskii arkhiv.  91 (2019)  4 - p. 53-61 , 2019
Link: https://doi.org/10.26442..
 
?
10

Evaluation of efficacy and comparative frequency of adverse..:

Knyazev, O V ; Shkurko, T V ; Kagramanova, A V...
Terapevticheskii arkhiv.  91 (2019)  8 - p. 41-46 , 2019
Link: https://doi.org/10.26442..
 
?
11

Efficacy and tolerability of certolizumab pegol in Crohn's ..:

Knyazev, O V ; Kagramanova, A V ; Lishchinskaya, A A...
Terapevticheskii arkhiv.  90 (2018)  6 - p. 74-80 , 2018
Link: https://doi.org/10.26442..
 
?
12

Clostridium difficile in inflammatory bowel disease:

Knyazev, O V ; Kagramanova, A V ; Chernova, M E..
Terapevticheskii arkhiv.  90 (2018)  11 - p. 32-36 , 2018
Link: https://doi.org/10.26442..
 
?
13

Personalized medicine in the treatment of inflammatory bowe..:

Parfenov, A I ; Knyazev, O V ; Kagramanova, A V.
Terapevticheskii arkhiv.  90 (2018)  2 - p. 4-11 , 2018
Link: https://doi.org/10.26442..
 
?
14

Stem Cell Therapy for Perianal Crohn's Disease:

Knyazev, O V ; Fadeeva, N A ; Kagramanova, A V...
Terapevticheskii arkhiv.  90 (2018)  3 - p. 60-66 , 2018
Link: https://doi.org/10.26442..
 
?
15

Adherence to therapy of patients with inflammatory bowel di..:

Parfenov, A I ; Kagramanova, A V ; Babayan, A F.
Terapevticheskii arkhiv.  90 (2018)  12 - p. 4-11 , 2018
Link: https://doi.org/10.26442..
 
1-15